Talc pharmaceutical industry ranks among the top 20 pharmaceutical enterprise research and development in China

The 2016-07-27 18:11:47

Source: shanxi daily

In chongqing on July 23 to 25, at the 33rd annual meeting of the national pharmaceutical industry information, talc pharmaceutical industry not only won the 2015 China's pharmaceutical industry enterprises, in 2015 China's pharmaceutical r&d product the best industrial enterprise, and ranks among the top 20 research and development of pharmaceutical enterprises in China. This is talc pharmaceutical industry to carry out the strategy of "going out" and to the internationalization, enterprise research and development into the Chinese drug development echelon.

In recent years, talc pharmaceutical on innovative drug research and development to explore out a "going out" and the combination of "introducing" internationalization development. With excellent technical superiority, talc will produce active pharmaceutical ingredients, pharmaceutical preparations and high-grade medicinal plastic bottles are exported to the United States, Japan and other developed countries, the international high-end market actively, participate in international competition. At the same time of "going out", talc pharmaceutical also actively with top scientific research institutions and large companies in the European and American countries in management, technology, products, and talent for international cooperation, strengthen the introduction, digestion, absorption and innovation ability, better to raise their level of development, meet the demand of domestic market.

Innovation is the inexhaustible power enterprise development. In recent years, talc pharmaceutical out sales revenue every year more than 8% of the funds for scientific and technological innovation, in research and development strategy constantly looking for new breakthrough and development mode. Strategy, taking "one to research and development, approval, production and sale of places," the internationalization strategy, the research and development in China, reporting in the United States, Europe, China, Hong Kong; Produced in China, sales in the United States, Europe, China, Hong Kong. Mode, take the "joint development" mode of international cooperation, has with the United States lilly, Britain's national institute for medical research, ministry of science and technology, Canada Lawson health research institute and other multinational companies or international first-class research institutions cooperation development for diabetes, Parkinson's disease, sepsis, stroke, and so on many kinds of innovative drugs.

(Li Ningbo chun-rong Yang)